Off-Target Cannabinoid Effects Mediated by GPR55

    Research output: Contribution to journalArticlepeer-review

    53 Citations (Scopus)

    Abstract

    Given the vast therapeutic potential of the endocannabinoid system, the revelation of a novel cannabinoid-sensitive target was treated with great excitement. The orphan G-protein coupled receptor 55 (GPR55) was initially touted as a novel cannabinoid target in early industrial patent literature. Consequently, numerous studies have revealed GPR55 expression in a diverse array of cells and tissues, regulating various physiological and pathological processes. Although a confusing cannabinoid profile has prevented its classification as a cannabinoid receptor, the therapeutic potential of the receptor cannot be denied, with roles in cancer progression, bone resorption and analgesia. This commentary aims to summarize GPR55 expression data and speculate on potential therapeutic exploitation of this enigmatic orphan receptor. Copyright (C) 2012 S. Karger AG, Basel
    Original languageEnglish
    Pages (from-to)179-187
    Number of pages9
    JournalPharmacology
    Volume89
    Issue number3-4
    DOIs
    Publication statusPublished - 2012

    Keywords

    • GPR55
    • Lysophosphatidylinositol
    • Cannabinoid
    • PROTEIN-COUPLED RECEPTOR
    • L-ALPHA-LYSOPHOSPHATIDYLINOSITOL
    • CANCER-CELL PROLIFERATION
    • ABNORMAL-CANNABIDIOL
    • LIGAND-BINDING
    • BREAST-CANCER
    • MESENTERIC VASODILATION
    • SYNAPTIC-TRANSMISSION
    • ENDOTHELIAL-CELLS
    • SELECTIVE LIGANDS

    Fingerprint

    Dive into the research topics of 'Off-Target Cannabinoid Effects Mediated by GPR55'. Together they form a unique fingerprint.

    Cite this